|
1
|
Hwang EY, Jeong MS, Park EK, Kim JH and
Jang SB: Structural characterization and interaction of periostin
and bone morphogenetic protein for regulation of collagen
cross-linking. Biochem Biophys Res Commun. 449:425–431. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Norris RA, Borg TK, Butcher JT, Baudino
TA, Banerjee I and Markwald RR: Neonatal and adult cardiovascular
pathophysiological remodeling and repair: Developmental role of
periostin. Ann N Y Acad Sci. 1123:30–40. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Horiuchi K, Amizuka N, Takeshita S,
Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF and Kudo A:
Identification and characterization of a novel protein, periostin,
with restricted expression to periostium and periodontal ligament
and increased expression by transforming growth factor beta. J Bone
Miner Res. 14:1239–1249. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Katsuragi N, Morishita R, Nakamura N,
Ochiai T, Taniyama Y, Hasegawa Y, Kawashima K, Kaneda Y, Ogihara T
and Sugimura K: Periostin as a novel factor responsible for
ventricular dilation. Circulation. 110:1806–1813. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang D, Oparil S, Feng JA, Li P, Perry G,
Chen LB, Dai M, John SW and Chen TF: Effects of pressure overload
on extracellular matrix expression in the heart of the atrial
natriuretic peptide-null mouse. Hypertension. 42:88–95. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilde J, Yokozeki M, Terai K, Kudo A and
Moriyama K: The divergent expression of periostin mRNA in the
periodontal ligament during experimental tooth movement. Cell
Tissue Res. 312:345–351. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruan K, Bao S and Ouyang G: The
multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci.
66:2219–2230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim CJ, Yoshioka N, Tambe Y, Kushima R,
Okada Y and Inoue H: Periostin is down-regulated in high grade
human bladder cancers and suppresses in vitro cell invasiveness and
in vivo metastasis of cancer cells. Int J Cancer. 117:51–58. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim CJ, Sakamoto K, Tambe Y and Inoue H:
Opposite regulation of epithelial-to-mesenchymal transition and
cell invasiveness by periostin between prostate and bladder cancer
cells. Int J Oncol. 38:1759–1766. 2011.PubMed/NCBI
|
|
10
|
Watanabe T, Shinohara N, Sazawa A,
Harabayashi T, Ogiso Y, Koyanagi T, Takiguchi M, Hashimoto A,
Kuzumaki N, Yamashita M, et al: An improved intravesical model
using human bladder cancer cell lines to optimize gene and other
therapies. Cancer Gene Ther. 7:1575–1580. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka M, Gee JR, De La Cerda J, Rosser
CJ, Zhou JH, Benedict WF and Grossman HB: Noninvasive detection of
bladder cancer in an orthotopic murine model with green
fluorescence protein cytology. J Urol. 170:975–978. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim CJ, Isono T, Tambe Y, Chano T, Okabe
H, Okada Y and Inoue H: Role of alternative splicing of periostin
in human bladder carcinogenesis. Int J Oncol. 32:161–169.
2008.PubMed/NCBI
|
|
13
|
Naviaux RK, Costanzi E, Haas M and Verma
IM: The pCL vector system: Rapid production of helper-free,
high-titer, recombinant retroviruses. J Virol. 70:5701–5705.
1996.PubMed/NCBI
|
|
14
|
Hansel DE, Platt E, Orloff M, Harwalker J,
Sethu S, Hicks JL, De Marzo A, Steinle RE, His ED, Theodorescu D,
et al: Mammalian target of rapamycin (mTOR) regulates cellular
proliferation and tumor growth in urothelial carcinoma. Am J
Pathol. 176:3062–3072. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gildea JJ, Herlevsen M, Harding MA,
Gulding KM, Moskaluk CA, Frierson HF and Theodorescu D: PTEN can
inhibit in vitro organotypic and in vivo orthotopic invasion of
human bladder cancer cells even in the absence of its lipid
phosphatase activity. Oncogene. 23:6788–6797. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun CH, Chang YH and Pan CC: Activation of
the PI3K/Akt/mTOR pathway correlates with tumour progression and
reduced survival in patients with urothelial carcinoma of the
urinary bladder. Histopathology. 58:1054–1063. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wan X, Mendoza A, Khanna C and Helman LJ:
Rapamycin inhibits ezrin-mediated metastatic behavior in a murine
model of osteosarcoma. Cancer Res. 65:2406–2411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Busch S, Renaud SJ, Schleussner E, Graham
CH and Markert UR: mTOR mediates human trophoblast invasion through
regulation of matrix-remodeling enzymes and is associated with
serine phosphorylation of STAT3. Exp Cell Res. 315:1724–1733. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berven LA, Willard FS and Crouch MF: Role
of the p70(S6K) pathway in regulating the actin cytoskeleton and
cell migration. Exp Cell Res. 296:183–195. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu L, Li F, Cardelli JA, Martin KA,
Blenis J and Huang S: Rapamycin inhibits cell motility by
suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene.
25:7029–7040. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu L, Chen L, Chung J and Huang S:
Rapamycin inhibits F-actin reorganization and phosphorylation of
focal adhesion proteins. Oncogene. 27:4998–5010. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lutzeyer W, Rübben H and Dahm H:
Prognostic parameters in superficial bladder cancer: An analysis of
315 cases. J Urol. 127:250–252. 1982.PubMed/NCBI
|
|
23
|
Herr HW, Laudone VP and Whitmore WF Jr: An
overview of intravesical therapy for superficial bladder tumors. J
Urol. 138:1363–1368. 1987.PubMed/NCBI
|
|
24
|
Soloway MS and Masters S: Urothelial
susceptibility to tumor cell implantation: Influence of
cauterization. Cancer. 46:1158–1163. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
See WA, Miller JS and Williams RD:
Pathophysiology of transitional tumor cell adherence to sites of
urothelial injury in rats: Mechanisms mediating intravesical
recurrence due to implantation. Cancer Res. 49:5414–5418.
1989.PubMed/NCBI
|
|
26
|
Sylvester RJ, Oosterlinck W and van der
Meijden AP: A single immediate postoperative instillation of
chemotherapy decreases the risk of recurrence in patients with
stage Ta T1 bladder cancer: A meta-analysis of published results of
randomized clinical trials. J Urol. 171:2186–2190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okamura K, Ono Y, Kinukawa T, Matsuura O,
Yamada S, Ando T, Fukatsu T, Ohno Y and Ohshima S: Nagoya
University Urological Oncology Group: Randomized study of a single
early instillation of (2′'R)-4′-O-tetrahydropyranyl-doxorubicin for
a single superficial bladder carcinoma. Cancer. 94:2363–2368. 2002.
View Article : Google Scholar : PubMed/NCBI
|
